EXPLAINER: What we know about AstraZeneca blood clot reports

EXPLAINER: What we know about AstraZeneca blood clot reports

3 years ago
Anonymous $hYN7Hy7o7J

https://apnews.com/3ce214ebf3b4a3167e44d114646faa2d

LONDON (AP) — German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people under 60 after more unusual blood clots were reported in a small number of people who received the shots.

Earlier this month, more than a dozen countries, including Germany, suspended their use of AstraZeneca over the blood clot issue. Most restarted — some with the kinds of restrictions Germany imposed Tuesday — after Europe's drug regulator said the benefits of the vaccine outweighed the risks of not inoculating people against COVID-19.

Last Seen
20 minutes ago
Reputation
0
Spam
0.000
Last Seen
33 minutes ago
Reputation
0
Spam
0.000
Last Seen
3 hours ago
Reputation
0
Spam
0.000
Last Seen
13 minutes ago
Reputation
0
Spam
0.000
Last Seen
about an hour ago
Reputation
0
Spam
0.000
Last Seen
24 minutes ago
Reputation
0
Spam
0.000